Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

Holdings in Q3 2024

Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.

Institution overview
Positions
63
0 vs. Q2 2024
Portfolio value
$1.70B
+$43.5M (+2.6%) vs. Q2 2024
Filed
Nov 14, 2024
SEC
Holdings of Redmile Group, LLC in Q3 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
KRYSKrystal Biotech, Inc.COM810,245$147.5M8.7%−210,833−20.6%ReducedHistory
NRIXNurix Therapeutics, Inc.COM4,280,981$96.2M5.7%−142,635−3.2%ReducedHistory
FOLDAmicus Therapeutics, Inc.COM8,246,592$88.1M5.2%−2,348,497−22.2%ReducedHistory
IMNMImmunome Inc.COM4,889,554$71.5M4.2%00.0%UnchangedHistory
KYMRKymera Therapeutics, Inc.COM1,393,256$65.9M3.9%−186,019−11.8%ReducedHistory
ZYMEZymeworks Inc.COM5,101,911$64.0M3.8%−109,126−2.1%ReducedHistory
STOKStoke Therapeutics, Inc.COM4,713,509$57.9M3.4%−7,545−0.2%ReducedHistory
REPLReplimune Group, Inc.COM4,781,183$52.4M3.1%−780,913−14.0%ReducedHistory
BHVNBiohaven Ltd.COM1,034,219$51.7M3.0%−53,357−4.9%ReducedHistory
RGNXREGENXBIO Inc.COM4,892,902$51.3M3.0%+323,100+7.1%AddedHistory
IGMSIGM Biosciences, Inc.COM3,072,478$50.8M3.0%00.0%UnchangedHistory
ADCTADC Therapeutics SASHS15,669,217$49.4M2.9%+400,000+2.6%AddedHistory
COGTCogent Biosciences, Inc.COM4,484,380$48.4M2.9%−315,593−6.6%ReducedHistory
FATEFate Therapeutics IncCOM13,169,057$46.1M2.7%00.0%UnchangedHistory
LIVNLivaNova PLCSHS875,039$46.0M2.7%−54,467−5.9%ReducedHistory
SRRKScholar Rock Holding CorpCOM5,238,837$42.0M2.5%−214,246−3.9%ReducedHistory
NGNENeurogene Inc.COM964,347$40.5M2.4%−49,316−4.9%ReducedHistory
AKROAkero Therapeutics, Inc.COM1,387,479$39.8M2.3%−226,994−14.1%ReducedHistory
BEAMBeam Therapeutics Inc.COM1,611,013$39.5M2.3%−92,048−5.4%ReducedHistory
AUGXAugmedix, Inc.COM16,380,327$38.5M2.3%00.0%UnchangedHistory
ANNXAnnexon, Inc.COM6,427,462$38.1M2.2%00.0%UnchangedHistory
CTLTCatalent, Inc.COM595,570$36.1M2.1%00.0%UnchangedHistory
PLRXPliant Therapeutics, Inc.COM3,197,491$35.8M2.1%−12,100−0.4%ReducedHistory
SLNSilence Therapeutics plcADS1,899,317$34.5M2.0%−114,979−5.7%ReducedHistory
KROSKeros Therapeutics, Inc.COM552,506$32.1M1.9%00.0%UnchangedHistory
ABSIAbsci CorpCOM8,253,316$31.5M1.9%00.0%UnchangedHistory
BSXBoston Scientific CorpStock330,873$27.7M1.6%−59,380−15.2%ReducedHistory
CLDXCelldex Therapeutics, Inc.COM NEW657,175$22.3M1.3%−61,548−8.6%ReducedHistory
IDYAIDEAYA Biosciences, Inc.COM681,150$21.6M1.3%−78,366−10.3%ReducedHistory
STTKShattuck Labs, Inc.COM5,615,489$19.6M1.2%00.0%UnchangedHistory
BNTXBioNTech SESPONSORED ADS154,456$18.3M1.1%+154,456NewHistory
IMVTImmunovant, Inc.COM642,229$18.3M1.1%−77,948−10.8%ReducedHistory
FDMT4D Molecular Therapeutics, Inc.COM1,262,090$13.6M0.8%+188,655+17.6%AddedHistory
ISRGIntuitive Surgical IncCOM NEW26,698$13.1M0.8%−13,145−33.0%ReducedHistory
SYKStryker CorpStock32,741$11.8M0.7%−6,742−17.1%ReducedHistory
ETNB89bio, Inc.COM1,569,850$11.6M0.7%−175,806−10.1%ReducedHistory
ARDXArdelyx, Inc.COM1,660,763$11.4M0.7%−220,738−11.7%ReducedHistory
ESTAEstablishment Labs Holdings Inc.COM261,803$11.3M0.7%+48,779+22.9%AddedHistory
ORKAOruka Therapeutics, Inc.COM411,728$10.1M0.6%+411,728NewHistory
PRMEPrime Medicine, Inc.COM2,074,350$8.03M0.5%00.0%UnchangedHistory
ALXOAlx Oncology Holdings IncCOM3,836,576$6.98M0.4%−199,875−5.0%ReducedHistory
NUVBNuvation Bio Inc.COM CL A3,031,009$6.94M0.4%00.0%UnchangedHistory
VERVVerve Therapeutics, Inc.COM1,383,366$6.70M0.4%−80,040−5.5%ReducedHistory
RPTXRepare Therapeutics Inc.COM1,942,555$6.68M0.4%00.0%UnchangedHistory
ACIUAC Immune SASHS1,694,167$6.40M0.4%−113,537−6.3%ReducedHistory
CYTKCytokinetics IncCOM NEW97,116$5.13M0.3%−14,751−13.2%ReducedHistory
VTYXVentyx Biosciences, Inc.COM2,107,215$4.59M0.3%−56,911−2.6%ReducedHistory
STXSStereotaxis, Inc.COM NEW2,108,219$4.30M0.3%00.0%UnchangedHistory
ATRAAtara Biotherapeutics, Inc.COM NEW452,270$3.68M0.2%00.0%UnchangedHistory
BOLDBoundless Bio, Inc.COM1,023,548$3.55M0.2%−11,035−1.1%ReducedHistory
LVTXLAVA Therapeutics NVSHS2,074,372$3.44M0.2%00.0%UnchangedHistory
ATXSAstria Therapeutics, Inc.COM310,884$3.42M0.2%+310,884NewHistory
IVVDInvivyd, Inc.COM3,065,714$3.13M0.2%00.0%UnchangedHistory
XERSXeris Biopharma Holdings, Inc.COM1,046,587$2.98M0.2%00.0%UnchangedHistory
GRTSGritstone bio, Inc.COM4,920,178$2.85M0.2%−187,554−3.7%ReducedHistory
PENPenumbra IncCOM13,847$2.69M0.2%+13,847NewHistory
CABACabaletta Bio, Inc.COM442,826$2.09M0.1%00.0%UnchangedHistory
ALLKAllakos Inc.COM3,077,828$2.01M0.1%00.0%UnchangedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS1,608,089$1.64M0.1%00.0%Unchanged–
KLRSKalaris Therapeutics, Inc.COM1,907,969$1.54M0.1%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM504,532$1.01M0.1%−32,150−6.0%ReducedHistory
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR715,607$680.1K<0.1%00.0%UnchangedHistory
HOOKHOOKIPA Pharma Inc.COM106,376$457.4K<0.1%00.0%UnchangedConverted for a 1-for-10 splitHistory

Sold out since Q2 2024 (4)

Positions held at the end of Q2 2024 that are gone from this filing.

Positions of Redmile Group, LLC sold out since Q2 2024
SecurityClassShares in Q2 2024Value in Q2 2024% of portfolio in Q2 2024History
BPMCBlueprint Medicines CorpCOM94,405$10.2M0.6%History
TRDAEntrada Therapeutics, Inc.COM560,971$7.99M0.5%History
LABStandard Biotools Inc.COM411,631$728.6K<0.1%History
TKNOAlpha Teknova, Inc.COM154,509$211.7K<0.1%History